Try our beta test site

CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2017 by Mayo Clinic
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Horng Chen, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01678794
First received: August 31, 2012
Last updated: March 24, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)